"Surgical Products Magazine featured the PDI Sani-Hands® Instant Sanitizing Wipes in the “Editor’s Choice” section of its November/December 2014 issue
Provides Topical Relief to Soldiers Stationed in Harsh Climate and Conditions
DermWORX™, a New Jersey based company that provides premium, non-prescription dermatology products to clinicians and their patients, announced its donation of a topical anesthetic to Soldiers’ Angels. The non-profit organization provides aid and comfort to the men and women of the United States Army, Marines, Navy, Air Force, Coast Guard, their families and a growing veteran population, including the sending of care packages of urgently needed items. Through Soldiers’ Angels, DermWORX provided $105,000 in product donations of LidoWORX™, a rapid-acting pain relief topical gel, to soldiers in need stationed in Africa, where climate conditions can be severe.
"When we learned about what Soldiers’ Angels does for the military and their families, there was no question that we wanted to help their cause. Fortunately, DermWORX has a very practical and effective product that could help provide some relief for soldiers stationed in areas with biting insects and harsh sun. We immediately jumped at the chance to make a donation,” said Tom Ford, chief executive officer of DermWORX.
LidoWORX is a fast-acting and effective dermal analgesic gel that provides temporary numbing and relief from pain and itching associated with sunburn, insect bites or other minor skin irritations. LidoWORX uses a special four percent lidocaine formula that conveniently acts fast and dries clean, making it ideal for mosquito or other insect bites and stings. The gel comes in a compact 0.4 ounce tube, suitable for soldiers on the move. It is available through physicians and skin health professionals across the U.S.
DermWORX is a New Jersey based company that develops premium, non-prescription dermatology products for clinicians and their patients. DermWORX brings a wide range of passions and experience to their product offerings, including scientific research, health education and advocacy, pharmaceuticals and manufacturing. For more information about DermWORX, visit www.DermWORX.com or www.facebook.com/DermWORX.
Celebrity Moms Star in Exergen TemporalScanner's “Game Time Temperature" Contest For Fall and Winter Sports BroadcastsNovember 20th, 2014
Exergen Corporation is placing the spotlight on its TemporalScanner thermometer by sponsoring Westwood One’s NFL, and Sports USA’s NFL and NCAA football radio broadcasts, as well as Performance Radio Network’s NASCAR Racing events. The radio spots – recorded by high profile moms – remind consumers that the TemporalScanner is a fast, accurate and non-invasive tool for identifying fever, the most important symptom of the flu. Most, of all, it makes busy moms’ lives easier.
The robust radio campaign features Wendy Venturini, the first woman anchor to announce a NASCAR race, Lauren Bohlander Kanaan, the wife of the 2013 Indy 500 winner Tony Kanaan, Nanci Kahn, wife of award-winning play-by-play announcer Larry Kahn, and Leah O’Brien-Amico, Gold Medal winner for USA Women’s Softball in 1996. All of the moms are users of the Exergen TemporalScanner, speaking first-hand from their experience.
Exergen is sponsoring a “Game-Time Temperature” contest throughout the football season. Fans can guess the game time temperature before it is announced on Westwood One and Sports Radio USA and win an Exergen TemporalScanner. For more information, visit www.gametimetemperature.com or the Exergen Facebook page at Facebook.com/ExergenCorporation. Similarly, via Performance Racing Network, NASCAR racing fans can guess the Green Flag Temperature to win a TemporalScanner.
“Our innovative technology has revolutionized the way the world takes temperatures, and who better than busy moms to share that message with millions of sports fans,” said Dr. Francesco Pompei, CEO of Exergen Corporation. “We know that a high percentage of sports fans are women and we want to let them know how it can make their lives easier when caring for sick infants and children.”
Exergen markets two models of the TemporalScanner thermometer: a professional version for doctors' offices and hospitals, and a consumer model sold in major retailers nationwide. Nearly two billion temperatures are taken each year with the TemporalScanner. It is used in thousands of hospitals, clinics and pediatricians' offices across the country, as well as in millions of homes. In addition to being the #1 preference of pediatricians in the US, it is the #1 preference of nurses, and the #1 selling retail thermometer. The Exergen TemporalScanner's performance is supported by more than 50 peer-reviewed published studies covering all ages from preterm infants to geriatrics and all care areas from hospitals to homes. For additional information, visit www.exergen.com.
Bacteria-Resistant Curtains Protect the Fabrics Surrounding Patients
X-STATIC® Antimicrobial Technology has been chosen by Nebraska Methodist Hospital to elevate its standard of care for fabrics in the healthcare environment. The facility will install bacteria-resistant Arc-Com privacy curtains powered by X-STATIC® in the Post Anesthesia Care Unit (PACU) of its new surgery center.
Terry Micheels, MSN, RN, CIC, and the Service Leader of the Epidemiology Department at Nebraska Methodist Hospital explained, “We have things we do to address soft surface fabric risk in the facility already. However, we felt a better solution was needed for the new PACU, which would contain a number of cubicle curtains for patient privacy needs.”
A 2012 study published in the American Journal of Infection Control concluded that privacy curtains are rapidly contaminated, with 92 percent showing contamination within one week. evaluated antimicrobial solutions and determined a technology which is permanently integrated into the product was optimal next to a temporary topical solution. The durability of X-STATIC, certified at 200+ commercial launderings, was a critical decision-making factor.
“Fabrics are contaminated and are a critical link in the chain of infection,” said Joel Furey, Chief Commercial Officer at Noble Biomaterials. “This means we must update policy and standard practice, follow proper cleaning procedures and understand what technologies are available to us to actively and continuously manage contamination.”
Peg Luebbert, MS, MT (ASCP), CIC, CHSP and Founder of Healthcare Interventions, LLC., offered suggestions for anyone evaluating soft surface fabric solutions: “I suggest you pay close attention to any kill claims made by antimicrobial fabric manufacturers and ensure those claims are backed by the appropriate approvals. For example, a fabric that claims it “kills MRSA” needs to have a public health claim approved by the Environmental Protection Agency (EPA). To my knowledge, there are no soft surface fabrics currently available that have the ability to make the kill claim.”
Luebbert also stressed that antimicrobials aren’t all the same and identified questions to ask: Is it currently registered as an antimicrobial with the EPA or is that pending? What is the durability and efficacy of the product? Is the end product certified, or is it just the technology?
Fabrics powered by X-STATIC® are the premier solution for bacterial management on scrubs, uniforms, privacy curtains, and lab coats. It is currently registered as an antimicrobial with the EPA and is the only company to certify the efficacy of its technology in finished products. X-STATIC® is made in the USA, has undergone extensive safety testing and is used by Olympic athletes, US armed services, premier athletic brand lululemon athletica inc, and many other leading consumer brands. For more information, visit www.InfectionPreventionTextiles.com“like” X-STATIC ® on Facebook or follow them on Twitter @XStaticFiber.
About Noble Biomaterials, Inc.
X-STATIC® is a registered trademark of Noble Fiber Technologies, LLC. Headquartered in Scranton, PA, Noble Biomaterials, Inc. develops, manufactures and markets advanced antimicrobial technologies designed to manage all forms of bacterial contamination. It has more than 200 global licensees for products in the medical, defense, industrial and consumer markets and the company's headquarters and manufacturing facilities are located in Scranton, PA, with offices in Europe, Asia and South America.
Hospital privacy curtains are frequently and rapidly contaminated with potentially pathogenic bacteria. American Journal of Infection Control. Volume 40, Issue 10; Pages 904-906, December 2012 http://www.ajicjournal.org/article/PIIS0196655312000703/abstract
New Randomized Study Shows 3.15% Chlorhexidine Gluconate/70% Isopropyl Alcohol Solution Most Effective for Disinfecting Needleless Access Sites at 5 Second Scrub TimeOctober 24th, 2014
PDI Prevantics® Device Swab is the only 3.15% Chlorhexidine Gluconate/70% alcohol solution to receive market authorization by the FDA
Clinical investigators recently released results from the first and only randomized, cross-over, prospective, comparative effectiveness clinical study evaluating the benefits of a 3.15% Chlorhexidine Gluconate (CHG) and 70% Isopropyl Alcohol over 70% Isopropyl Alcohol alone in disinfecting needleless connectors. The study was funded by the US Centers for Disease Control and Prevention (CDC) Epicenters Program and executed by Rush University in Chicago, IL. The results were presented at the 2014 IDWeek Conference in Philadelphia, PA, on October 11, 2014.
The findings align with CDC Guidelines which state: “Some studies have shown that disinfection of the devices with chlorhexidine/alcohol solutions appears to be most effective in reducing colonization.” The investigators determined that the CHG and alcohol scrub resulted in less needleless connector contamination than an alcohol scrub at a five second scrub time. Prevantics® Device Swab from PDI, leading provider of infection prevention solutions, is the only 3.15% Chlorhexidine Gluconate and 70% Isopropyl Alcohol solution that has received market authorization from the U.S. Food and Drug Administration (FDA) for disinfecting needleless access sites prior to use.
“This study answers a previously unknown clinical question about the most efficacious antiseptic for disinfection of needleless access sites and also ideal prep times,” said Hudson Garrett, PhD, Vice-President, Clinical Affairs for PDI. “This study demonstrates the importance of targeted efforts to reduce contamination on needleless access sites and ensure evidence-based practices for disinfection of needleless access sites.”
The PDI Prevantics® Device Swab is fully compliant with the evidence-based guidelines and recommendations from the US Centers for Disease Control and Prevention (CDC), the Infusion Nurses Society, the Association for Vascular Access, and the Association for Professionals in Infection Control and Epidemiology.
PDI helps reduce preventable infections, control healthcare costs, and ultimately help save lives by delivering a broad range of evidence-based, market leading skin antisepsis, environmental hygiene and patient care solutions. PDI’s expertise in making a difference in the community and healthcare environments extends throughout the United States and worldwide. pdihc.com